勃起功能障碍和心血管危险因素

Hospital practice Pub Date : 2001-08-15 DOI:10.3810/hp.2001.08.246

R. Kloner

{"title":"勃起功能障碍和心血管危险因素","authors":"R. Kloner","doi":"10.3810/hp.2001.08.246","DOIUrl":null,"url":null,"abstract":"Erectile dysfunction (ED) affects as many as 30 million men in the United States. Its risk factors are similar to those for atherosclerotic heart disease. Physicians should ask male patients—particularly those with cardiovascular disease-about ED and men with confirmed ED about cardiovascular risk factors. Oral sildenafil is an effective therapy for both organic and psychogenic ED; it is contraindicated in patients taking organic nitrates.","PeriodicalId":75913,"journal":{"name":"Hospital practice","volume":"36 1","pages":"41 - 51"},"PeriodicalIF":0.0000,"publicationDate":"2001-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3810/hp.2001.08.246","citationCount":"17","resultStr":"{\"title\":\"Erectile Dysfunction and Cardiovascular Risk Factors\",\"authors\":\"R. Kloner\",\"doi\":\"10.3810/hp.2001.08.246\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Erectile dysfunction (ED) affects as many as 30 million men in the United States. Its risk factors are similar to those for atherosclerotic heart disease. Physicians should ask male patients—particularly those with cardiovascular disease-about ED and men with confirmed ED about cardiovascular risk factors. Oral sildenafil is an effective therapy for both organic and psychogenic ED; it is contraindicated in patients taking organic nitrates.\",\"PeriodicalId\":75913,\"journal\":{\"name\":\"Hospital practice\",\"volume\":\"36 1\",\"pages\":\"41 - 51\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2001-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3810/hp.2001.08.246\",\"citationCount\":\"17\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hospital practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3810/hp.2001.08.246\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3810/hp.2001.08.246","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 17

摘要

在美国，勃起功能障碍(ED)影响着多达3000万男性。其危险因素与动脉粥样硬化性心脏病相似。医生应该询问男性患者——尤其是那些有心血管疾病的患者——关于ED的情况，并询问确诊ED的男性心血管危险因素。口服西地那非对器质性和心因性ED均有效;服用有机硝酸盐的患者禁用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Erectile Dysfunction and Cardiovascular Risk Factors

Erectile dysfunction (ED) affects as many as 30 million men in the United States. Its risk factors are similar to those for atherosclerotic heart disease. Physicians should ask male patients—particularly those with cardiovascular disease-about ED and men with confirmed ED about cardiovascular risk factors. Oral sildenafil is an effective therapy for both organic and psychogenic ED; it is contraindicated in patients taking organic nitrates.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hospital practice

自引率

0.00%

发文量